by NadrichCohenLLP
May 3, 2012
Personal Injury
Boehringer Ingelheim, maker of the increasingly popular anticoagulant drug Pradaxa, has announced that it will establish a new patient registry which will allow the company to track the safety of Pradaxa for patients suffering from a heart rhythm condition known as atrial fibrillation (AF). The GLORIA(TM)-AF Registry is expected to be completed in 2020 and […]
Read the full blawg post →
by NadrichCohenLLP
April 14, 2012
Personal Injury
The blood-thinning drug Pradaxa (dabigatran) has been linked to a number of serious complications, including an increased risk of serious and in some cases, fatal, bleeding events. Boehringer Ingelheim, the company that manufactures Pradaxa, acknowledged in November 2011 that the drug was responsible for approximatley 260 deaths worldwide. A new report issued by the Food […]
Read the full blawg post →